Explore the complete record of transactions filed by 成正辉, Director. Insider active across 1 companies, notably 惠泰医疗. Cumulatively, 44 reports have been logged. Regulator: AMF. All data is free.
Declarations 44 total
Executives ● Purchase惠 惠泰医疗 7 SSE 10,000 shares
SSE:273000000615639230 · 14 May 2026
Ideal exit: 8 Feb 2027 (T+270) Executives ● Purchase一 一心堂 7 SZSE 1,359,000 shares
SZSE:273000000606293660 · 12 May 2026
Ideal exit: 6 Feb 2027 (T+270) Executives ● Purchase广 广钢气体 12 SSE 4,596 shares
SSE:273000000183673820 · 10 Feb 2026
Ideal exit: 7 Nov 2026 (T+270) Executives ● Purchase一 一心堂 7 SZSE 1,550,700 shares
SZSE:273000000037371620 · 17 Dec 2025
Ideal exit: 13 Sept 2026 (T+270) 1,761,400 shares
SZSE:273000000037884160 · 17 Dec 2025
Executives ● Sale英 英诺激光 22 SZSE 2,800 shares
SZSE:173000009573067170 · 22 Sept 2025
2,164,739 shares
SSE:173000009518584320 · 11 Sept 2025
Executives ● Sale惠 惠泰医疗 11 SSE 29,943 shares
SSE:173000008879613900 · 29 Apr 2025
Executives ● Purchase广 广钢气体 8 SSE 10,100 shares
SSE:173000008783476450 · 10 Apr 2025
Ideal exit: 5 Jan 2026 (T+270) Executives ● Purchase全 全筑股份 7 SSE 81,800 shares
SSE:173000008362519230 · 19 Dec 2024
Ideal exit: 15 Sept 2025 (T+270) Executives ● Purchase广 广钢气体 8 SSE 84,440 shares
SSE:173000008117076500 · 24 Sept 2024
Ideal exit: 21 Jun 2025 (T+270) Executives ● Purchase全 全筑股份 7 SSE 89,900 shares
SSE:173000008109353950 · 20 Sept 2024
Ideal exit: 17 Jun 2025 (T+270) Executives ● Purchase全 全筑股份 7 SSE 88,500 shares
SSE:173000008109354000 · 20 Sept 2024
Ideal exit: 17 Jun 2025 (T+270) Executives ● Purchase全 全筑股份 7 SSE 40,000 shares
SSE:173000008106818050 · 19 Sept 2024
Ideal exit: 16 Jun 2025 (T+270) Executives ● Purchase全 全筑股份 7 SSE 203,300 shares
SSE:173000008103651200 · 18 Sept 2024
Ideal exit: 15 Jun 2025 (T+270) Executives ● Purchase英 英诺激光 23 SZSE 3,000 shares
SZSE:173000007946740350 · 12 Aug 2024
Ideal exit: 9 May 2025 (T+270) Executives ● Purchase英 英诺激光 15 SZSE 200 shares
SZSE:173000007942541000 · 9 Aug 2024
Ideal exit: 6 May 2025 (T+270) Executives ● Purchase全 全筑股份 11 SSE 100,000 shares
SSE:173000007850657120 · 17 Jul 2024
Ideal exit: 13 Apr 2025 (T+270) Executives ● Purchase华 华英农业 14 SZSE 174,300 shares
SZSE:173000007639761180 · 13 May 2024
Ideal exit: 7 Feb 2025 (T+270) Executives ● Purchase英 英诺激光 19 SZSE 6,300 shares
SZSE:173000007502898900 · 16 Apr 2024
Ideal exit: 11 Jan 2025 (T+270) Executives ● Purchase英 英诺激光 19 SZSE 5,900 shares
SZSE:173000007498554430 · 15 Apr 2024
Ideal exit: 10 Jan 2025 (T+270) Executives ● Purchase华 华英农业 7 SZSE 2,437,400 shares
SZSE:173000007381152740 · 8 Mar 2024
Ideal exit: 3 Dec 2024 (T+270) 2,374 shares
SSE:173000007307411260 · 5 Feb 2024
Executives ● Purchase一 一心堂 7 SZSE 23,800 shares
SZSE:173000007180783360 · 21 Dec 2023
Ideal exit: 16 Sept 2024 (T+270) Executives ● Purchase广 广钢气体 12 SSE 20,000 shares
SSE:173000006825130300 · 21 Aug 2023
Ideal exit: 17 May 2024 (T+270) 25 of 44 declarations
Load more (19 remaining) About 成正辉 Cheng Zhenghui is a board member and senior executive at Huitai Medical. He plays an essential role in the strategic direction of the company and in making important decisions. His management experience is an asset to Huitai Medical.